459 related articles for article (PubMed ID: 32214382)
1. Cervicovaginal microbiome and natural history of HPV in a longitudinal study.
Usyk M; Zolnik CP; Castle PE; Porras C; Herrero R; Gradissimo A; Gonzalez P; Safaeian M; Schiffman M; Burk RD;
PLoS Pathog; 2020 Mar; 16(3):e1008376. PubMed ID: 32214382
[TBL] [Abstract][Full Text] [Related]
2. Predictive functional analysis reveals inferred features unique to cervicovaginal microbiota of African women with bacterial vaginosis and high-risk human papillomavirus infection.
Onywera H; Anejo-Okopi J; Mwapagha LM; Okendo J; Williamson AL
PLoS One; 2021; 16(6):e0253218. PubMed ID: 34143825
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus infection and cervical intraepithelial neoplasia progression are associated with increased vaginal microbiome diversity in a Chinese cohort.
Chen Y; Qiu X; Wang W; Li D; Wu A; Hong Z; Di W; Qiu L
BMC Infect Dis; 2020 Aug; 20(1):629. PubMed ID: 32842982
[TBL] [Abstract][Full Text] [Related]
4. Cervical microbiota dysbiosis associated with high-risk Human Papillomavirus infection.
Zeber-Lubecka N; Kulecka M; Dabrowska M; Baginska-Drabiuk K; Glowienka-Stodolak M; Nowakowski A; Slabuszewska-Jozwiak A; Bednorz B; Jędrzejewska I; Piasecka M; Pawelec J; Wojciechowska-Lampka E; Ostrowski J
PLoS One; 2024; 19(4):e0302270. PubMed ID: 38669258
[TBL] [Abstract][Full Text] [Related]
5. The vaginal microbiota associates with the regression of untreated cervical intraepithelial neoplasia 2 lesions.
Mitra A; MacIntyre DA; Ntritsos G; Smith A; Tsilidis KK; Marchesi JR; Bennett PR; Moscicki AB; Kyrgiou M
Nat Commun; 2020 Apr; 11(1):1999. PubMed ID: 32332850
[TBL] [Abstract][Full Text] [Related]
6. Changes of the vaginal microbiota in HPV infection and cervical intraepithelial neoplasia: a cross-sectional analysis.
Lin W; Zhang Q; Chen Y; Dong B; Xue H; Lei H; Lu Y; Wei X; Sun P
Sci Rep; 2022 Feb; 12(1):2812. PubMed ID: 35181685
[TBL] [Abstract][Full Text] [Related]
7. Cervical intraepithelial neoplasia disease progression is associated with increased vaginal microbiome diversity.
Mitra A; MacIntyre DA; Lee YS; Smith A; Marchesi JR; Lehne B; Bhatia R; Lyons D; Paraskevaidis E; Li JV; Holmes E; Nicholson JK; Bennett PR; Kyrgiou M
Sci Rep; 2015 Nov; 5():16865. PubMed ID: 26574055
[TBL] [Abstract][Full Text] [Related]
8. The vaginal microbiota, human papillomavirus and cervical dysplasia: a systematic review and network meta-analysis.
Norenhag J; Du J; Olovsson M; Verstraelen H; Engstrand L; Brusselaers N
BJOG; 2020 Jan; 127(2):171-180. PubMed ID: 31237400
[TBL] [Abstract][Full Text] [Related]
9. Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study.
Dalstein V; Riethmuller D; Prétet JL; Le Bail Carval K; Sautière JL; Carbillet JP; Kantelip B; Schaal JP; Mougin C
Int J Cancer; 2003 Sep; 106(3):396-403. PubMed ID: 12845680
[TBL] [Abstract][Full Text] [Related]
10. Cervical Squamous Intraepithelial Lesions Are Associated with Differences in the Vaginal Microbiota of Mexican Women.
Nieves-Ramírez ME; Partida-Rodríguez O; Moran P; Serrano-Vázquez A; Pérez-Juárez H; Pérez-Rodríguez ME; Arrieta MC; Ximénez-García C; Finlay BB
Microbiol Spectr; 2021 Oct; 9(2):e0014321. PubMed ID: 34643408
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of the Cervicovaginal Microenvironment in Childbearing-Age Women with Different Degrees of Cervical Lesions and HR-HPV Positivity.
Zhai Q; Zhang W; Zhang Z; Fu Y; Li Y; Wang X; Li L; Meng Y
Pol J Microbiol; 2021 Dec; 70(4):489-500. PubMed ID: 34970317
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of the bivalent HPV vaccine against HPV 16/18-associated precancer: long-term follow-up results from the Costa Rica Vaccine Trial.
Porras C; Tsang SH; Herrero R; Guillén D; Darragh TM; Stoler MH; Hildesheim A; Wagner S; Boland J; Lowy DR; Schiller JT; Schiffman M; Schussler J; Gail MH; Quint W; Ocampo R; Morales J; Rodríguez AC; Hu S; Sampson JN; Kreimer AR;
Lancet Oncol; 2020 Dec; 21(12):1643-1652. PubMed ID: 33271093
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the cervical microbiome and potential biomarkers from postpartum HIV-positive women displaying cervical intraepithelial lesions.
Curty G; Costa RL; Siqueira JD; Meyrelles AI; Machado ES; Soares EA; Soares MA
Sci Rep; 2017 Dec; 7(1):17364. PubMed ID: 29234019
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of Human Papillomavirus Genotypes Among Women With High-Grade Cervical Lesions in Beijing, China.
Xiao M; Xu Q; Li H; Gao H; Bie Y; Zhang Z
Medicine (Baltimore); 2016 Jan; 95(3):e2555. PubMed ID: 26817906
[TBL] [Abstract][Full Text] [Related]
15. Potential impact of combined high- and low-risk human papillomavirus infection on the progression of cervical intraepithelial neoplasia 2.
Okadome M; Saito T; Tanaka H; Nogawa T; Furuta R; Watanabe K; Kita T; Yamamoto K; Mikami M; Takizawa K;
J Obstet Gynaecol Res; 2014 Feb; 40(2):561-9. PubMed ID: 24147758
[TBL] [Abstract][Full Text] [Related]
16. Changes to the cervicovaginal microbiota and cervical cytokine profile following surgery for cervical intraepithelial neoplasia.
Kawahara R; Fujii T; Kukimoto I; Nomura H; Kawasaki R; Nishio E; Ichikawa R; Tsukamoto T; Iwata A
Sci Rep; 2021 Jan; 11(1):2156. PubMed ID: 33495564
[TBL] [Abstract][Full Text] [Related]
17. Precancerous cervical lesions caused by non-vaccine-preventable HPV types after vaccination with the bivalent AS04-adjuvanted HPV vaccine: an analysis of the long-term follow-up study from the randomised Costa Rica HPV Vaccine Trial.
Shing JZ; Hu S; Herrero R; Hildesheim A; Porras C; Sampson JN; Schussler J; Schiller JT; Lowy DR; Sierra MS; Carvajal L; Kreimer AR;
Lancet Oncol; 2022 Jul; 23(7):940-949. PubMed ID: 35709811
[TBL] [Abstract][Full Text] [Related]
18. Competing-risks regression models in analysis of biomarkers as predictors of high-risk human papillomavirus (HPV) infection outcomes and incident CIN in the LAMS cohort.
Syrjänen S; Longhato-Filho A; Sarian LO; Naud P; Derchain S; Rottelli-Martins C; Tatti S; Branca M; Eržen M; Hammes LS; Matos J; Gontijo R; Bragança J; Arlindo FC; Maeda MY; Costa S; Syrjänen K
Int J Gynecol Pathol; 2013 Jul; 32(4):406-15. PubMed ID: 23722514
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptors: Important immune checkpoints in the regression of cervical intra-epithelial neoplasia 2.
Halec G; Scott ME; Farhat S; Darragh TM; Moscicki AB
Int J Cancer; 2018 Dec; 143(11):2884-2891. PubMed ID: 30121951
[TBL] [Abstract][Full Text] [Related]
20. Dual staining for p16/Ki-67 to detect high-grade cervical lesions: Results from the Screening Triage Ascertaining Intraepithelial Neoplasia by Immunostain Testing study.
El-Zein M; Gotlieb W; Gilbert L; Hemmings R; Behr MA; Franco EL;
Int J Cancer; 2021 Jan; 148(2):492-501. PubMed ID: 32781481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
